-
1Electronic Resource
المؤلفون: Deftereos I., Yeung J.M., Arslan J., Carter V.M., Isenring E., Kiss N., Cardamis A., Dorey A., Ottaway A., Maguire B., Cleeve B., Davis C., Zoanetti C., Gray C., Choong C., Douglas C., Nixon C., Platt D., Quinn E., Simpson E., Hamdorf E., McNamara E., Whelan E., Jegendran G., Moore G., Lockwood G., McNamara J., Corrigan J., Haaksma K., Fox K., Furness K., Cochrane K.W., Huynh K., Lee K.C., Hames N., Hendricks N., Page N., Brooks N., Nevin L., Parfrey L., Putrus E., Pons R., Hoevenaars R., Singh S., McCoy S., Wallin S., Mexias S., Daniells S., Storr T., Robertson T., Brown T.
مصطلحات الفهرس: Article
URL: Clinical Nutrition ESPEN
-
2Electronic Resource
المؤلفون: Deftereos I., Yeung J.M., Arslan J., Carter V.M., Isenring E., Kiss N., Cardamis A., Dorey A., Ottaway A., Maguire B., Cleeve B., Davis C., Zoanetti C., Gray C., Choong C., Douglas C., Nixon C., Platt D., Quinn E., Simpson E., Hamdorf E., McNamara E., Whelan E., Jegendran G., Moore G., Lockwood G., McNamara J., Corrigan J., Haaksma K., Fox K., Furness K., Cochrane K.W., Huynh K., Lee K.C., Hames N., Hendricks N., Page N., Brooks N., Nevin L., Parfrey L., Putrus E., Pons R., Hoevenaars R., Singh S., McCoy S., Wallin S., Mexias S., Daniells S., Storr T., Robertson T., Brown T.
مصطلحات الفهرس: Article
URL: Clinical Nutrition ESPEN
LibKey Link -
3Electronic Resource
المؤلفون: Deftereos I., Yeung J.M., Arslan J., Carter V.M., Isenring E., Kiss N., Cardamis A., Dorey A., Ottaway A., Maguire B., Cleeve B., Davis C., Zoanetti C., Gray C., Choong C., Douglas C., Nixon C., Platt D., Quinn E., Simpson E., Hamdorf E., McNamara E., Whelan E., Jegendran G., Moore G., Lockwood G., McNamara J., Corrigan J., Haaksma K., Fox K., Furness K., Cochrane K.W., Huynh K., Lee K.C., Hames N., Hendricks N., Page N., Brooks N., Nevin L., Parfrey L., Putrus E., Pons R., Hoevenaars R., Singh S., McCoy S., Wallin S., Mexias S., Daniells S., Storr T., Robertson T., Brown T.
مصطلحات الفهرس: Article
URL: Clinical Nutrition ESPEN
LibKey Link -
4Electronic Resource
المؤلفون: Woolley I., Dart A., Mijch A., Nyulasi I., Jolley D., Carter V.M.
مصطلحات الفهرس: human, Human immunodeficiency virus infected patient, Human immunodeficiency virus infection/dt [Drug Therapy], hypertriglyceridemia/co [Complication], hypertriglyceridemia/dt [Drug Therapy], hypertriglyceridemia/th [Therapy], male, randomized controlled trial, statistical significance, therapy effect, treatment duration, triacylglycerol blood level, antiretrovirus agent/cb [Drug Combination], antiretrovirus agent/dt [Drug Therapy], enfuvirtide/cb [Drug Combination], enfuvirtide/dt [Drug Therapy], fish oil/ct [Clinical Trial], fish oil/dt [Drug Therapy], fish oil/po [Oral Drug Administration], fish oil/pd [Pharmacology], nucleoside/cb [Drug Combination], nucleoside/dt [Drug Therapy], nucleoside analog/cb [Drug Combination], nucleoside analog/dt [Drug Therapy], olive oil, omega 3 fatty acid/ct [Clinical Trial], omega 3 fatty acid/dt [Drug Therapy], omega 3 fatty acid/po [Oral Drug Administration], omega 3 fatty acid/pd [Pharmacology], placebo, proteinase inhibitor/cb [Drug Combination], adult, article, clinical article, clinical trial, confidence interval, controlled clinical trial, controlled study, diet restriction, diet supplementation, diet therapy, double blind procedure, drug effect, drug efficacy, fat intake, highly active antiretroviral therapy, HIV associated lipodystrophy/co [Complication], HIV associated lipodystrophy/dt [Drug Therapy], HIV associated lipodystrophy/th [Therapy], proteinase inhibitor/dt [Drug Therapy], RNA directed DNA polymerase inhibitor/cb [Drug Combination], RNA directed DNA polymerase inhibitor/dt [Drug Therapy], triacylglycerol/ec [Endogenous Compound], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/32150
Click here for full text options
LibKey Link -
5Electronic Resource
المؤلفون: Woolley I., Dart A., Mijch A., Nyulasi I., Jolley D., Carter V.M.
مصطلحات الفهرس: human, Human immunodeficiency virus infected patient, Human immunodeficiency virus infection/dt [Drug Therapy], hypertriglyceridemia/co [Complication], hypertriglyceridemia/dt [Drug Therapy], hypertriglyceridemia/th [Therapy], male, randomized controlled trial, statistical significance, therapy effect, treatment duration, triacylglycerol blood level, antiretrovirus agent/cb [Drug Combination], antiretrovirus agent/dt [Drug Therapy], enfuvirtide/cb [Drug Combination], enfuvirtide/dt [Drug Therapy], fish oil/ct [Clinical Trial], fish oil/dt [Drug Therapy], fish oil/po [Oral Drug Administration], fish oil/pd [Pharmacology], nucleoside/cb [Drug Combination], nucleoside/dt [Drug Therapy], nucleoside analog/cb [Drug Combination], nucleoside analog/dt [Drug Therapy], olive oil, omega 3 fatty acid/ct [Clinical Trial], omega 3 fatty acid/dt [Drug Therapy], omega 3 fatty acid/po [Oral Drug Administration], omega 3 fatty acid/pd [Pharmacology], placebo, proteinase inhibitor/cb [Drug Combination], adult, article, clinical article, clinical trial, confidence interval, controlled clinical trial, controlled study, diet restriction, diet supplementation, diet therapy, double blind procedure, drug effect, drug efficacy, fat intake, highly active antiretroviral therapy, HIV associated lipodystrophy/co [Complication], HIV associated lipodystrophy/dt [Drug Therapy], HIV associated lipodystrophy/th [Therapy], proteinase inhibitor/dt [Drug Therapy], RNA directed DNA polymerase inhibitor/cb [Drug Combination], RNA directed DNA polymerase inhibitor/dt [Drug Therapy], triacylglycerol/ec [Endogenous Compound], Article